Reversible cardiomyopathy caused by administration of interferon α

被引：0
|
作者：
Aarif Y Khakoo
Marc K Halushka
J Eduardo Rame
E Rene Rodriguez
Edward K Kasper
Daniel P Judge
机构：
[1] Division of Cardiology,Department of Pathology
[2] Johns Hopkins University,undefined
来源：
Nature Clinical Practice Cardiovascular Medicine | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background A 56-year-old man with normal cardiac function received treatment with interferon α-2b for malignant melanoma. Eight months after the initiation of therapy he developed fatigue and dyspnea on exertion. Two months later, he was admitted to hospital with ORTHOPNEA, worsening dyspnea and cough. Physical examination findings were consistent with congestive heart failure. Laboratory studies were notable for hypothyroidism. Echocardiography revealed severe, global left-ventricular dysfunction.
引用
收藏
页码：53 / 57
页数：4
相关论文
共 50 条
  • [1] Reversible cardiomyopathy caused by administration of interferon α
    Khakoo, AY
    Halushka, MK
    Rame, JE
    Rodriguez, ER
    Kasper, EK
    Judge, DP
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (01): : 53 - 57
  • [2] REVERSIBLE CARDIOMYOPATHY INDUCED BY INTERFERON
    SONNENBLICK, M
    ROSENMANN, D
    ROSIN, A
    BRITISH MEDICAL JOURNAL, 1990, 300 (6733): : 1174 - 1175
  • [3] REVERSIBLE CARDIOMYOPATHY INDUCED BY INTERFERON
    GUILLOT, P
    BARBUAT, C
    RICHARD, B
    JOURDAN, J
    THERAPIE, 1993, 48 (01): : 65 - 66
  • [4] Reversible cardiomyopathy secondary to α-interferon in an infant
    Angulo, MP
    Navajas, A
    Galdeano, JM
    Astigarraga, I
    Fernández-Teijeiro, A
    PEDIATRIC CARDIOLOGY, 1999, 20 (04) : 293 - 294
  • [5] Reversible Cardiomyopathy Secondary to α-Interferon in an Infant
    M.P. Angulo
    A. Navajas
    J.M. Galdeano
    I. Astigarraga
    A. Fernández-Teijeiro
    Pediatric Cardiology, 1999, 20 : 293 - 294
  • [6] Reversible Cardiomyopathy After Epirubicin Administration
    Koitabashi, Notimichi
    Ohyama, Yoshiaki
    Tateno, Rieko
    Arai, Masashi
    Rokutanda, Nana
    Horiguchi, Jun
    Kurabayashi, Masahiko
    INTERNATIONAL HEART JOURNAL, 2015, 56 (04) : 466 - 468
  • [7] Reversible hyperthyroidism and cardiomyopathy caused by consumption of iodocasein
    Donega, P
    Gallerani, M
    Vigna, GB
    Fellin, R
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 320 (02): : 148 - 150
  • [8] Reversible dilated cardiomyopathy caused by idiopathic hypoparathyroidism
    Jung, Youn Joo
    Kim, Sung Eun
    Hong, Ji Yeon
    Lee, Jun Hee
    Park, Dae Gyun
    Han, Kyoo Rok
    Oh, Dong Jin
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2013, 28 (05): : 605 - 608
  • [9] Interferon-Alpha Caused Reversible Parkinsonism
    Lu, Chieh-Sheng
    Kao, Wei-Yau
    Lin, Jiann-Chyun
    Chang, Ping-Ying
    CLINICAL NEUROPHARMACOLOGY, 2015, 38 (03) : 119 - 120
  • [10] A case of reversible dilated cardiomyopathy caused by Takayasu arteritis
    Shin, S-H Sung-Hee
    Jang, J. H.
    kwon, S. W.
    Park, S. D.
    Woo, S. I.
    Kim, D. H.
    Kwan, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 18 - 18
12345